Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.

The model was highly significant [F (5,166) = 10.1; p<0.001] and predicted approximately 23% (R 2 ) of the variance in the outcome variable.

also in 132,142 other papers

These results were consistent when patients were further stratified on the basis of their LILRA3+/+ ( Fig 4B ) or LILRA3+/- ( Fig 4C ) genotype, although some did not reach statistical significance.

also in 111,027 other papers